| 0.981 | 0.002 | 0.981 | Antiadrenergic | | |
| 0.981 | 0.002 | 0.981 | Adrenaline antagonist | | |
| 0.961 | 0.003 | 0.961 | Cardiotonic | | |
| 0.793 | 0.001 | 0.793 | Beta adrenoreceptor antagonist | | |
| 0.599 | 0.02 | 0.599 | Antiobesity | | |
| 0.481 | 0.002 | 0.481 | Beta 1 adrenoreceptor antagonist | | |
| 0.482 | 0.006 | 0.482 | Cholinergic | | |
| 0.47 | 0.06 | 0.47 | Cyclophilin D inhibitor | | |
| 0.41 | 0.002 | 0.41 | Beta 2 adrenoreceptor antagonist | | |
| 0.414 | 0.021 | 0.414 | Vasodilator | | |
| 0.385 | 0.002 | 0.385 | Beta 3 adrenoreceptor antagonist | | |
| 0.423 | 0.048 | 0.423 | Vasodilator, peripheral | | |
| 0.388 | 0.043 | 0.388 | Spasmolytic | | |
| 0.309 | 0.013 | 0.309 | Acetylcholine M1 receptor antagonist | | |
| 0.333 | 0.064 | 0.333 | Vasodilator, coronary | | |
| 0.259 | 0.002 | 0.259 | Calcium-sensing receptor antagonist | | |
| 0.224 | 0.005 | 0.224 | Acetylcholine muscarinic agonist | | |
| 0.222 | 0.003 | 0.222 | Acetylcholine M2 receptor agonist | | |
| 0.285 | 0.093 | 0.285 | Sodium/bile acid cotransporter inhibitor | | |
| 0.206 | 0.031 | 0.206 | Anesthetic local | | |
| 0.177 | 0.008 | 0.177 | Acetylcholine M3 receptor agonist | | |
| 0.174 | 0.01 | 0.174 | Adrenaline agonist | | |
| 0.187 | 0.028 | 0.187 | Acetylcholine muscarinic antagonist | | |
| 0.184 | 0.037 | 0.184 | Cholinergic antagonist | | |
| 0.177 | 0.037 | 0.177 | Acetylcholine antagonist | | |
| 0.161 | 0.023 | 0.161 | Acetylcholine agonist | | |
| 0.149 | 0.013 | 0.149 | Factor XII inhibitor | | |
| 0.224 | 0.097 | 0.224 | Tyrosine 3 hydroxylase inhibitor | | |
| 0.115 | 0.004 | 0.115 | Nitric oxide donor | | |
| 0.13 | 0.039 | 0.13 | Bronchodilator | | |
| 0.155 | 0.065 | 0.155 | Lipid peroxidase inhibitor | | |
| 0.127 | 0.045 | 0.127 | Alpha adrenoreceptor antagonist | | |
| 0.142 | 0.06 | 0.142 | Alpha-N-acetylglucosaminidase inhibitor | | |
| 0.084 | 0.015 | 0.084 | Acetylcholine M1 receptor agonist | | |
| 0.074 | 0.007 | 0.074 | Acetylcholine M4 receptor agonist | | |
| 0.072 | 0.009 | 0.072 | Sphingosine 1-phosphate receptor 3 agonist | | |
| 0.161 | 0.1 | 0.161 | P-glycoprotein inhibitor | | |
| 0.139 | 0.084 | 0.139 | Adenylate cyclase stimulant | | |
| 0.211 | 0.157 | 0.211 | Angiogenesis inhibitor | | |
| 0.089 | 0.036 | 0.089 | 5 Hydroxytryptamine 1A antagonist | | |
| 0.064 | 0.014 | 0.064 | Cholesterol esterase inhibitor | | |
| 0.057 | 0.01 | 0.057 | Beta adrenoreceptor agonist | | |
| 0.071 | 0.025 | 0.071 | Gonadotropin-releasing hormone receptor agonist | | |
| 0.143 | 0.1 | 0.143 | Interleukin 6 antagonist | | |
| 0.083 | 0.045 | 0.083 | 5 Hydroxytryptamine 1 antagonist | | |
| 0.066 | 0.029 | 0.066 | Beta 2 adrenoreceptor agonist | | |
| 0.109 | 0.087 | 0.109 | Nav1.3 sodium channel blocker | | |
| 0.169 | 0.149 | 0.169 | Peptidyltransferase inhibitor | | |
| 0.045 | 0.028 | 0.045 | HIV-1 protease inhibitor | | |
| 0.08 | 0.066 | 0.08 | Alpha 2 adrenoreceptor antagonist | | |
| 0.037 | 0.029 | 0.037 | Vascular adhesion protein 1 inhibitor | | |